Here’s a roundup of recent clinical trial news:
- Pulmonx Reports Scientific Publication and Presentations Highlighting Key Advances in Emphysema Treatment
Pulmonx, an emerging leader in interventional pulmonology, announced that the New England Journal of Medicine has published the results of the largest prospective, randomized, controlled study completed to date of endobronchial approaches to emphysema treatment, the VENT Study (Endobronchial Valve for Emphysema PalliatioN Trial).
Read more - MAQUET Cardiovascular Announces Enrollment of First Patient in Study Evaluating Best-Practice Endoscopic Vein Harvesting in Coronary Artery Bypass Surgery
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.
Read more - Stentys Self-Apposing Stent Proves Superior to Conventional Treatment of Acute Myocardial Infarction
Stentys, which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced positive results from an international clinical trial, the APPOSITION II study.
Read more - Post-Market Approval Study of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for Lower Limb Vascular Disease Completes Patient Enrollment
W. L. Gore & Associates (Gore) reported the complete enrollment in a post-market approval study designed to better characterize the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in treating peripheral vascular disease (PVD) of the superficial femoral artery (SFA).
Read more - Entellus Medical Study Demonstrates That Balloon Dilation to Treat CRS Can Be Performed Safely in the Clinic with Symptom Improvements
Entellus Medical, a Minnesota-based medical technology company, shared the results of a 12-month study entitled “Clinic versus OR – A Comparative Analysis of Ostial Dilation for CRS,” presented on September 25th during the 56th annual meeting of the American Rhinologic Society in Boston, Mass.
Read more - Published Study Shows PEM Sensitivity Equivalent to Breast MRI
In a prospective study published in the European Journal of Nuclear Medicine and Molecular Imaging, researchers at Boca Raton Regional Hospital (Boca Raton, FL) showed that Positron Emission Mammography (PEM) and breast MRI had comparably high ability to detect cancerous lesions.
Read more - Artimplant: Artelon Cosmetic Study Confirms Product Application – Publication Accepted by Clinical Implant Dentistry and Related Research
A post-market study has been conducted by the Brånemark Clinic in Gothenburg on Artelon Cosmetic for soft tissue augmentation in the upper jaw.
Read more - Two Clinical Case Reports Demonstrate Trend Accuracy of Masimo Noninvasive and Continuous Hemoglobin and Illustrates Its Use as an Effective Tool for Blood Conservation
Masimo (NSDQ:MASI) announced that two new clinical case reports presented at the Society for the Advancement of Blood Management (SABM) Annual Meeting demonstrate that Masimo noninvasive and continuous hemoglobin (SpHb) provides measurements as accurate as invasive laboratory blood tests, offering a “new and effective strategy to facilitate blood conservation efforts and minimize unnecessary transfusions in the intensive care unit (ICU).”
Read more - Endologix Announces Publication of Positive Outcomes Data
Endologix, Inc. (NSDQ:ELGX), developer of minimally invasive treatments for aortic disorders, announced the online publication of a long-term outcome analysis of abdominal aortic aneurysm (AAA) patients from the pivotal, multicenter, prospective clinical trials for the Company’s Powerlink System.
Read more - Urovalve Announces Early Successful Results in 13 Patients Treated in Clinical Trial of Its Surinate Bladder Management System
Urovalve, a medical device company focused on creating superior products for urinary flow and control, reported that early results are promising in a multi-site clinical study of the Company’s Surinate Bladder Management System.
Read more - ISTO Technologies Completes Enrollment in Phase I NuQu Clinical Trial
ISTO Technologies Inc., an orthobiologics company with a cell based platform for cartilage regeneration, announced the completion of patient enrollment in the Phase I clinical study for NuQu, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain.
Read more - SpinalMotion Completes Enrollment in International Clinical Study for Kineflex Lateral Lumbar Disc
SpinalMotion, Inc., developer of the investigational Kineflex lumbar and Kineflex|C cervical disc implants for treating patients with degenerative disc disease (DDD), reported that it has completed enrollment in an international clinical study evaluating the Kineflex lumbar artificial disc inserted via a minimally invasive lateral approach.
Read more - CardioDx Multi-Center Trial Validates Blood-Based Gene Expression Test to Assess the Presence of Obstructive Coronary Artery Disease
CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, announced publication of results from the Personalized Risk Evaluation and Diagnosis In the Coronary Tree (PREDICT) trial in the Annals of Internal Medicine, the journal of the American College of Physicians.
Read more - BIOTRONIK: REPLACE Registry Results Published in Circulation
BIOTRONIK, Inc., a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technologies, announced that results from the REPLACE Registry will be published in the October 19 issue of Circulation and have been published online.
Read more - NIH blood pressure trial expands to include more older adults
The National Institutes of Health plans to add about 1,750 participants over the age of 75 to its upcoming Systolic Blood Pressure Intervention Trial (SPRINT) to determine whether a lower blood pressure range in older adults will reduce cardiovascular and kidney diseases, age-related cognitive decline, and dementia.
Read more - Medtronic’s Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
Medtronic, Inc. (NYSE:MDT) announced the publication of results from a multicenter, prospective study that demonstrated that the company’s Reveal Plus implantable cardiac monitor recorded arrhythmias in 46 percent of patients with ejection fractions less than or equal to 40 percent and who had previously suffered an acute myocardial infarction (AMI).
Read more - Three U.S. Hospitals Reduce Costly Catheter-Related Bloodstream Infections
Clinicians from three U.S. hospitals reported significant progress in the fight against deadly IV catheter-related bloodstream infections (CRBSI). Data analyzed and presented by clinicians from St. Joseph’s Mercy Hospital in Hot Springs, Ark.; Bethesda North Hospital in Cincinnati; and the VA Medical Center in Seattle showed that the hospitals virtually eliminated such infections, which annually kill some 62,500 hospital patients nationwide.
Read more - Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc. (NYSE:MDT), announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference. The company also announced the start of a key clinical study of the IN.PACT Admiral (DEB) for the treatment of superficial femoral artery (SFA) disease.
Read more
